{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:51:00Z","timestamp":1792183860901,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":1053,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005643","name":"Baxter International Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005643","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1186\/s13613-023-01224-8","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T05:07:20Z","timestamp":1702616840000},"page":"127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effects of enhanced adsorption haemofiltration versus haemoadsorption in severe, refractory septic shock with high levels of endotoxemia: the ENDoX bicentric, randomized, controlled trial"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-3279","authenticated-orcid":false,"given":"Pedro David","family":"Wendel-Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Kleinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias Peter","family":"Hilty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Spanaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Maggiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1186\/s13613-023-01224-8_bb0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1186\/s13613-023-01224-8_bb0015","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1097\/01.CCM.0000288082.99980.90","article-title":"Expanding the global epidemiology of sepsis*","volume":"35","author":"Cribbs","year":"2007","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-023-01224-8_bb0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1526-0968.2003.00005.x","article-title":"Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)","volume":"7","author":"Shoji","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1186\/s13613-023-01224-8_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000499520","article-title":"Extracorporeal blood purification therapies for sepsis","volume":"47","author":"Monard","year":"2019","journal-title":"Blood Purif"},{"issue":"1","key":"10.1186\/s13613-023-01224-8_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","article-title":"In vitro comparison of the adsorption of inflammatory mediators by blood purification devices","volume":"6","author":"Malard","year":"2018","journal-title":"Intensive Care Med Exp"},{"issue":"2","key":"10.1186\/s13613-023-01224-8_bb0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ndt\/gfn518","article-title":"High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs","volume":"24","author":"Rimmel\u00e9","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1186\/s13613-023-01224-8_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000046966","article-title":"Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis","volume":"19","author":"Nemoto","year":"2001","journal-title":"Blood Purif"},{"issue":"5","key":"10.1186\/s13613-023-01224-8_bb0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.shk.0000159930.87737.8a","article-title":"A pilot-controlled study of A polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection","volume":"23","author":"Vincent","year":"2005","journal-title":"Shock"},{"issue":"23","key":"10.1186\/s13613-023-01224-8_bb0050","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1186\/s13613-023-01224-8_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000444474","article-title":"Potential survival benefit of polymyxin B hemoperfusion in septic shock patients on continuous renal replacement therapy: a propensity-matched analysis","volume":"42","author":"Iwagami","year":"2016","journal-title":"Blood Purif"},{"issue":"1","key":"10.1186\/s13613-023-01224-8_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13054-017-1712-3","article-title":"Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study","volume":"21","author":"Nakamura","year":"2017","journal-title":"Crit Care"},{"key":"10.1186\/s13613-023-01224-8_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000499589","article-title":"Continuous renal replacement therapy with the adsorbing filter oXiris in septic patients: a case series","volume":"47","author":"Turani","year":"2019","journal-title":"Blood Purif"},{"key":"10.1186\/s13613-023-01224-8_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000499510","article-title":"oXiris\u00ae use in septic shock: experience of two French centres","volume":"47","author":"Schwindenhammer","year":"2019","journal-title":"Blood Purif"},{"issue":"8","key":"10.1186\/s13613-023-01224-8_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220444","article-title":"Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study","volume":"14","author":"Broman","year":"2019","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1186\/s13613-023-01224-8_bb0080","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","article-title":"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial","volume":"41","author":"Payen","year":"2015","journal-title":"Intensive Care Med"},{"issue":"14","key":"10.1186\/s13613-023-01224-8_bb0085","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1186\/s13613-023-01224-8_bb0090","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","article-title":"Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial","volume":"44","author":"Klein","year":"2018","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1186\/s13613-023-01224-8_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0022-1759(98)00003-9","article-title":"A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence","volume":"212","author":"Romaschin","year":"1998","journal-title":"J Immunol Methods"},{"issue":"6","key":"10.1186\/s13613-023-01224-8_bb0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/cc11495","article-title":"Bench-to-bedside review: clinical experience with the endotoxin activity assay","volume":"16","author":"Romaschin","year":"2012","journal-title":"Crit Care"},{"issue":"4","key":"10.1186\/s13613-023-01224-8_bb0105","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1186\/s13613-023-01224-8_bb0110","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"the Aw","year":"2004","journal-title":"Crit Care"},{"issue":"2","key":"10.1186\/s13613-023-01224-8_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-023-01224-8_bb0120","first-page":"S98","article-title":"Endotoxin activity in sepsis and septic shock","volume":"38","author":"Hilty","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-023-01224-8_bb0125","author":"Team RC","year":"2013"},{"issue":"1","key":"10.1186\/s13613-023-01224-8_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-121-1-199407010-00001","article-title":"Treatment of septic shock with human monoclonal antibody HA-1A","volume":"121","author":"McCloskey","year":"1994","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1186\/s13613-023-01224-8_bb0135","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.283.13.1723","article-title":"E5 Murine monoclonal antiendotoxin antibody in gram-negative sepsisA randomized controlled trial","volume":"283","author":"Angus","year":"2000","journal-title":"JAMA"},{"issue":"11","key":"10.1186\/s13613-023-01224-8_bb0140","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1097\/CCM.0b013e3181b0266c","article-title":"Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial","volume":"37","author":"Phillip Dellinger","year":"2009","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1186\/s13613-023-01224-8_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000475982","article-title":"Novel insights into the direct removal of endotoxin by polymyxin B hemoperfusion","volume":"44","author":"Romaschin","year":"2017","journal-title":"Blood Purif"},{"issue":"1","key":"10.1186\/s13613-023-01224-8_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13613-016-0155-3","article-title":"The effects of direct hemoperfusion using a polymyxin B-immobilized column in a pig model of severe Pseudomonas aeruginosa pneumonia","volume":"6","author":"Li Bassi","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"3","key":"10.1186\/s13613-023-01224-8_bb0155","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.CCM.0000115262.31804.46","article-title":"Extracorporeal removal for sepsis: acting at the tissue level\u2014the beginning of a new era for this treatment modality in septic shock *","volume":"32","author":"Honor\u00e9","year":"2004","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1186\/s13613-023-01224-8_bb0160","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/cc13969","article-title":"Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat model","volume":"18","author":"Peng","year":"2014","journal-title":"Crit Care"},{"issue":"4","key":"10.1186\/s13613-023-01224-8_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000491744","article-title":"Mortality effects of prolonged hemoperfusion therapy using a polymyxin B-immobilized fiber column for patients with septic shock: a sub-analysis of the DESIRE trial","volume":"46","author":"Kawazoe","year":"2018","journal-title":"Blood Purif"},{"issue":"1","key":"10.1186\/s13613-023-01224-8_bb0170","doi-asserted-by":"crossref","first-page":"24132","DOI":"10.1038\/s41598-021-03055-8","article-title":"Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1186\/s13613-023-01224-8_bb0175","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/mas.20258","article-title":"Structural investigation of bacterial lipopolysaccharides by mass spectrometry and tandem mass spectrometry","volume":"29","author":"Banoub","year":"2010","journal-title":"Mass Spectrom Rev"},{"issue":"5","key":"10.1186\/s13613-023-01224-8_bb0180","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10156-013-0567-z","article-title":"Interleukin-8 induces an elevation in the endotoxin activity assay (EAA) level: does the EAA truly measure the endotoxin level?","volume":"19","author":"Matsumoto","year":"2013","journal-title":"J Infect Chemother"},{"issue":"11","key":"10.1186\/s13613-023-01224-8_bb0185","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s00134-021-06512-0","article-title":"Cytokine adsorption in severe, refractory septic shock","volume":"47","author":"Wendel Garcia","year":"2021","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1186\/s13613-023-01224-8_bb0190","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-021-06501-3","article-title":"High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial","volume":"47","author":"Garbero","year":"2021","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1186\/s13613-023-01224-8_bb0195","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V76.12.2520.2520","article-title":"Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways","volume":"76","author":"van Deventer","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1186\/s13613-023-01224-8_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00003246-200102000-00020","article-title":"Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response","volume":"29","author":"Taylor","year":"2001","journal-title":"Crit Care Med"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-023-01224-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-023-01224-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025005862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025005862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-023-01224-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:40:56Z","timestamp":1776670856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025005862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2110582025005862"],"URL":"https:\/\/doi.org\/10.1186\/s13613-023-01224-8","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of enhanced adsorption haemofiltration versus haemoadsorption in severe, refractory septic shock with high levels of endotoxemia: the ENDoX bicentric, randomized, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-023-01224-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The Author(s) 2023. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"127"}}